Jin Yang Wen
Plus aucun poste en cours
Profil
Jin Yang Wen is the founder of Aldea Pharmaceuticals, Inc. Prior to founding Aldea Pharmaceuticals, he worked as the Vice President at Eiger BioPharmaceuticals, Inc. and as the Chief Scientific Officer at Foresee Pharmaceuticals Co., Ltd.
Dr. Wen received his undergraduate degree from Chinese Culture University and his doctorate degree from the University of California.
Anciens postes connus de Jin Yang Wen
| Sociétés | Poste | Fin |
|---|---|---|
Aldea Pharmaceuticals, Inc.
 Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aldea Pharmaceuticals, Inc. develops novel enzyme activators to enhance the removal of toxic aldehydes. It targets Aldehyde metabolism dysfunction which is associated with a variety of diseases from acute alcohol toxicity to orphan indications such as Fanconi anemia. The company was founded by Daria Mochly-Rosen, Che-Hong Chen and Wenjin Yang in 2011 and is headquartered in Redwood City, CA. | Fondateur | - |
| EIGER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| FORESEE PHARMACEUTICALS CO., LTD. | Corporate Officer/Principal | - |
Formation de Jin Yang Wen
| University of California | Doctorate Degree |
| Chinese Culture University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| FORESEE PHARMACEUTICALS CO., LTD. | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Aldea Pharmaceuticals, Inc.
Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aldea Pharmaceuticals, Inc. develops novel enzyme activators to enhance the removal of toxic aldehydes. It targets Aldehyde metabolism dysfunction which is associated with a variety of diseases from acute alcohol toxicity to orphan indications such as Fanconi anemia. The company was founded by Daria Mochly-Rosen, Che-Hong Chen and Wenjin Yang in 2011 and is headquartered in Redwood City, CA. | Health Technology |
